Background: Widespread use of new oral anticoagulants (NOAG) for Atrial Fibrillation (A-Fib) has increased the annual incidence of gastrointestinal bleed (GIB) in recent years. These NOAG agents in our study include Rivaroxaban, Apixaban and Dabigatran. Convenience of use, quick onset, broad therapeutic window and eliminating need for frequent monitoring makes NOAGs attractive for A-Fib associated [...]

Case Presentation: 48-year-old African American (AA) male with history of Non-ischemic cardiomyopathy on milrinone (EF: 15%), after CHOP therapy for his lymphoma, diabetes mellitus, polysubstance abuse was admitted with an acute exacerbation of chronic systolic heart failure with cardiogenic shock. He was being managed with milrinone drip and lasix in the CCU and considered a [...]